PhageNova Bio, Inc.
- Biotech or pharma, therapeutic R&D
Our engineered hybrid bacteriophage AAV vector combines the targeting of phage and the sustained gene expression of an AAV. We are initially targeting cancer by expressing TNF specifically and exclusively at the site of cancer.
Address
Agoura HillsCalifornia
United States
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}